Home
overview
“Promises to be an interesting and informative conference” Dr Walter Koch, Roche

Microarray technology allows the simultaneous analysis of thousands of parameters within a single experiment. This exciting technology is revolutionising the way we look at genes and is already proving to be beneficial in the drug discovery process.

Microarray Technology: Commercial and Technical Issues looks at the current and evolving technologies and the applications that can be used with this technology. In addition to this we have experts speaking on a variety of important issues including the manufacturing of arrays and experimental design. This important conference introduces a wide range of scientific speakers presenting the most pressing issues within Microarray Technology whilst providing you with an in-depth analysis of the developments and potential of the biochip market.

Benefits of attending:

  • Meet the key specialists in Microarray Technology presenting on the emerging technologies and recent advances in Microarrays
  • Understand about data capture and quality
  • Learn about new novel technologies
  • Find out about the clinical applications of microarrays
  • Gain insight into the market directions and potential

    A unique opportunity to learn from leading industry experts including:
    Dr Larry Gelbert, Research Scientist & Group Leader, Funtional Genomics, Eli Lilly
    Dr Tarif Awad, Manager, Data Analysis Team, Genomic Collaborations, Affymetrix
    Dr Mischa Reinhardt, Head, Life Science Informatics, Novartis
    Dr Christian Hofmann, Associate Director, Business Development, Roche
    Dr Hilary Clark, Bioinformatics Scientist, Genentech
    Dr Mikhail Soloviev, Head, Protein Assays, Oxford GlycoSciences
    Dr Thomas Joos, Head Biochemistry, Natural and Medical Sciences Institute at the University of Tuebingen presenting on behalf of Luminex
    Dr Alex Chenchik, Director, Gene Cloning, Clontech
    Dr Robert Klein, Vice-President, Technology Development, Deltagen
    Jim George, European Applications Specialist, Amersham Biosciences
    Igor Ivanov, Director, GPC Biotech

  • Conference programme

    8:30 Registration and Coffee

    9:00 Chairman's Opening Remarks

    Dr Larry Gelbert

    Dr Larry Gelbert, Research Scientist & Group Leader, Functional Genomics, Eli Lilly

    9:10 THE FUTURE AND VISION OF MICROARRAY TECHNOLOGY

    Dr Christian Hofmann

    Dr Christian Hofmann, Associate Director, Business Development, Roche

  • Genetic profiling and prescriptions
  • Disease susceptibility
  • Accurate dose determination
  • Microarrays as diagnostic tools
  • 9:40 THE xMAP SUSPENSION ARRAY

    Dr Thomas Joos

    Dr Thomas Joos, Head Biochemistry, Natural and Medical Sciences Institute at the University of Tuebingen presenting on behalf of, Luminex

  • xMAP technology description
  • Benefits of 3D arrays vs 2D arrays
  • Clinical applications
  • Proteomic applications
  • Genetic screening and profiling
  • Drug discovery and high-throughput screening

    Future developments

  • 10:20 EXPRESSION MICROARRAY TECHNOLOGY

    Dr Mischa Reinhardt

    Dr Mischa Reinhardt, Executive Director, Head, Life Science Informatics, Novartis

  • Collecting information
  • Making experiments comparable
  • Advanced analysis methodologies
  • Integration with our genomic data domains
  • Gaining insight into biological systems
  • 11:00 Morning Coffee

    11:20 DO IT YOURSELF ARRAYS

    Dr Roland Green

    Dr Roland Green, Chief Technology Officer & Vice President, Research & Development, NimbleGen Systems

  • Gene expression arrays
  • Genotyping arrays
  • High-density format
  • High-throughput format
  • 12:00 BUILDING A VIABLE PROTEIN MICROARRAY

    Dr Karin Hughes

    Dr Karin Hughes, Vice President, Research & Development, Prolinx

  • The nature of proteins, protein stability
  • Identifying a surface chemistry
  • Selection of capture reagents
  • Pitfalls of printing
  • Choosing a detection method
  • 12:40 Networking Lunch

    14:00 RECENT ADVANCES IN MICROARRAY TECHNOLOGY

    Dr Mikhail Soloviev

    Dr Mikhail Soloviev, Head, Protein Assays, Oxford GlycoSciences

  • Protein microarrays at Oxford Glycosciences
  • Linking antibodies to solid support
  • Background issues

    Obtaining quantitative data with affinity arrays

  • Multiplexed affinity assays

    Oxford Glycosciences’ signal displacement assays

  • Protein arrays and mass spectrometry

    The use of peptides vs proteins

  • Peptide capture on an antibody chip
  • 14:40 THE HAPLOTYPE DIRECT – A WORLD FIRST

    Ray Harrison

    Ray Harrison, Chief Business Officer, Point-2-Point Genomics

  • Maternal and Paternal chromosomal haplotype available directly
  • No more algorithm approximation from single SNP analysis
  • Vast reduction in data points, slash numbers for clinical trials
  • HAP discovery and rountine HAP maps for each individual
  • Viral strain differentiation – PAP smear replacement potential
  • 15:20 APPLICATIONS OF MICROARRAY TECHNOLOGY

    Dr Tarif Awad

    Dr Tarif Awad, Senior Scientist, Genomics Collaborations, Affymetrix

  • Expression microarrays: target validation & discovery, toxicology
  • Getting the most out of data
  • GeneChip expression arrays in basic and applied research
  • Target validation study
  • Experimental design, data analysis, data interpretation
  • 16:00 Chairman’s Closing Remarks followed by Afternoon Tea
    Close of Day One

    8:30 Re-registration and Coffee

    9:00 Chairman's Opening Remarks

    Dr Robert Klein

    Dr Robert Klein, Vice President, Technology Development, Deltagen

    9:10 DESIGNING DNA MICROARRAYS

    Dr Don Montgomery

    Dr Don Montgomery, Chief Technology Officer & Vice-President, Research & Development, NimbleGen Systems

  • CBMX Semiconductor biochip technology
  • MatriXarray system
  • DNA probe design and optimisation
  • Rapid prototyping and customisation
  • Scaleable manufacturing
  • 9:40 EMERGING TECHNOLOGIES

    Dr Alex Chenchik

    Dr Alex Chenchik, Director, Gene Cloning & Analysis, BDB Clontech

  • Quality of array data and universal calibration standards
  • Normalisation and gene expression databases
  • Cross platform data comparison
  • Perfect probe technology
  • Biases in RNA amplification techniques
  • 10:20 CASE STUDY

    Dr Julian Burke

    Dr Julian Burke, Chief Scientific Officer, Genetix

  • Innovation in research and development
  • Nature of the market
  • Microarraying
  • Scanning
  • Proteomics & cell biology
  • 11:00 Morning Coffee

    11:20 IMMUNE DISEASE DRUG TARGET DISCOVERY

    Dr Hilary Clark

    Dr Hilary Clark, Bioinformatics Scientist, Genentech

  • Immune system specific expression as one criterion
  • Panel of microarray experiments on important subsets of immune cells
  • Broad survey of expression in immune cells vs all other tissue categories
  • Identify disease upregulation in immune cell types
  • Focus by considering known immune gene characteristics
  • Establishing a pipeline for immune gene assessment
  • 12:00 RESEARCH APPLICATIONS

    Douglas Lane

    Douglas Lane, CEO, ViaLogy

  • Data analysis
  • Data capture and bioinformatics
  • Variability
  • Data quality
  • Sample preparation and amplification
  • Standardisation between experiments
  • 12:40 Networking Lunch

    14:00 HIGH PERFORMANCE IN MICROARRAY EXPERIMENTS

    Jim George

    Jim George, European Applications Specialist, Amersham Biosciences

  • Customised and prearrayed slides: overview of the Lucidea platform and CodeLink platform
  • Quality control and its benefits
  • Diagnostics, what’s next?
  • 14:40 PATENTING AND LICENSING ISSUES

    Sarah Turner

    Sarah Turner, Senior Solicitor, Lovells

  • The importance of intellectual property
  • Patent strategies
  • Patent conflicts
  • Freedom to operate
  • Research tools
  • Licensing strategies

    Practical steps to protecting your investment

  • 15:20 Afternoon Tea

    15:40 CURRENT MARKET TRENDS

    Andreas Schafer

    Andreas Schafer, Associate Director, Qiagen

  • Size and growth of the market
  • Division of the market
  • Technological shifts and advances
  • The next generation arrays
  • Market shares
  • Market opportunities
  • 16:20 APPLICATIONS IN DRUG DISCOVERY

    Igor Ivanoff

    Igor Ivanoff, Director, GPC Biotech

  • Technological aspect: industrialisation and high throughput
  • Experimental design: concentrations, time, mutants
  • Statistical aspects of biological meaning
  • Validation using functional assays
  • 17:00 Chairman's Closing Remarks and Close of Conference

    +

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.